Loan & DebtMay 28, 2026, 08:01 AM
Bionano Genomics Retires $20M Senior Secured Convertible Debentures
AI Summary
Bionano Genomics, Inc. announced the full retirement and cancellation of its $20 million Senior Secured Convertible Debentures, originally issued in May 2024. The company utilized cash on hand to complete this debt restructuring, resulting in no outstanding secured debt obligations. This action releases all liens on company assets and extinguishes associated restrictive covenants, providing Bionano with significantly enhanced financial and operational flexibility to focus on its commercial strategy and optical genome mapping adoption.
Key Highlights
- Bionano Genomics fully retired and cancelled $20,000,000 in Senior Secured Convertible Debentures.
- The debentures were originally issued in May 2024.
- The company used cash on hand to retire the debt.
- This action completes the debt restructuring initiated in May 2024.
- Bionano now carries no outstanding secured debt obligations.
- All liens on the company's assets are released, and restrictive covenants are extinguished.
- The retirement provides greater financial and operational flexibility.
Price Impact
More from BNGO